Michael Gong

This publication record appears to mix several unrelated research areas, most notably prostate and urologic cancer topics such as active surveillance, biopsy outcomes, and T-cell based therapy for prostate cancer, alongside unrelated topics like autophagy protein structure, cardiovascular senescence, and case reports in gastroenterology and endocrinology. Because the name 'Michael Gong' may correspond to multiple distinct researchers or the data source has merged several authors' work, prospective students should treat this profile as uncertain and verify specific projects directly with the institution. The clearest recurring focus across entries is prostate and urologic cancer research, including active surveillance, risk stratification, and cell-based cancer therapies.

Publication counts over the last decade are irregular, with a notable spike in 2023 followed by lower output in 2024-2025, suggesting an inconsistent or possibly merged publication record rather than a steady growth pattern.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026